Skip to Main Content

Merck & Co., Inc.

MRK Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

$MRK stock is featured in our Congress Long-Short, Congress Sells, and Dan Meuser strategies.

See All Strategies
Income
Balance Sheet
Cash Flow
MRK Income Statement
MRK Balance Sheet
MRK Cash Flow

Recent trades of MRK by members of U.S. Congress

Politician Type Traded
Jared Moskowitz House / D Purchase $1,001 - $15,000 Nov. 08, 2024
Jonathan L. Jackson House / D Sale $15,001 - $50,000 Sep. 24, 2024
John James House / R Sale $1,001 - $15,000 Sep. 04, 2024
C. Scott Franklin House / R Purchase $1,001 - $15,000 Aug. 02, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 02, 2024
Josh Gottheimer House / D Sale $1,001 - $15,000 Jun. 21, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Apr. 10, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan. 23, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan. 23, 2024
Kathy E. Manning House / D Purchase $15,001 - $50,000 Jan. 23, 2024
Jared Moskowitz House / D Purchase $1,001 - $15,000 Dec. 28, 2023
Jared Moskowitz House / D Purchase $1,001 - $15,000 Dec. 28, 2023
John James House / R Purchase $1,001 - $15,000 Nov. 10, 2023
HON. GREG STANTON House / D Sale $1,001 - $15,000 Oct. 24, 2023
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Oct. 16, 2023
HON. GREG STANTON House / D Purchase $1,001 - $15,000 Sep. 26, 2023
Pete Ricketts Senate / R Sale (Full) $50,001 - $100,000 Sep. 21, 2023
Michael C. Burgess House / R Sale $1,001 - $15,000 Sep. 13, 2023
C. Scott Franklin House / R Sale $15,001 - $50,000 Sep. 11, 2023
Lois Frankel House / D Sale $1,001 - $15,000 Sep. 08, 2023
Lois Frankel House / D Sale $1,001 - $15,000 Sep. 06, 2023
Jared Moskowitz House / D Purchase $1,001 - $15,000 Sep. 01, 2023
Lois Frankel House / D Sale $1,001 - $15,000 Aug. 02, 2023
Daniel S. Goldman House / D Sale $1,001 - $15,000 Jul. 14, 2023
Jared Moskowitz House / D Purchase $1,001 - $15,000 Jul. 14, 2023
Daniel S. Goldman House / D Sale $1,001 - $15,000 Jul. 12, 2023
Lois Frankel House / D Sale $1,001 - $15,000 Jun. 28, 2023
Zoe Lofgren House / D Sale $1,001 - $15,000 May. 25, 2023
Daniel S. Goldman House / D Purchase $1,001 - $15,000 Apr. 10, 2023
Daniel S. Goldman House / D Sale $15,001 - $50,000 Mar. 06, 2023
Jared Moskowitz House / D Purchase $1,001 - $15,000 Feb. 24, 2023
Daniel S. Goldman House / D Purchase $1,001 - $15,000 Jan. 31, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Jan. 11, 2023
Kathy E. Manning House / D Purchase $1,001 - $15,000 Sep. 12, 2022
Kathy E. Manning House / D Sale $1,001 - $15,000 Aug. 05, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 15, 2022
Rick Larsen House / D Purchase $1,001 - $15,000 Jul. 07, 2022
Lois Frankel House / D Sale $1,001 - $15,000 Jun. 01, 2022
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Mar. 30, 2022
John H. Rutherford House / R Sale $1,001 - $15,000 Mar. 16, 2022
Robert J. Wittman House / R Sale $1,001 - $15,000 Feb. 28, 2022
Lois Frankel House / D Purchase $1,001 - $15,000 Dec. 03, 2021
Bob Gibbs House / R Purchase $1,001 - $15,000 Nov. 26, 2021
Zoe Lofgren House / D Purchase $1,001 - $15,000 Sep. 30, 2021
Katherine M. Clark House / D Sale $1,001 - $15,000 Sep. 16, 2021
Carol D. Miller House / R Sale $15,001 - $50,000 Jul. 28, 2021
Katherine M. Clark House / D Purchase $1,001 - $15,000 Jul. 27, 2021
Katherine M. Clark House / D Purchase $1,001 - $15,000 Jul. 27, 2021
John R. Curtis House / R Sale $1,001 - $15,000 Jul. 19, 2021
John W. Hickenlooper Senate / D Exchange $1,001 - $15,000 Jun. 02, 2021
MRK Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
MRK Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MRK Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by MRK's directors and management

Government lobbying spending instances

  • $2,190,000 Oct 21, 2024 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $3,010,000 Jul 22, 2024 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,190,000 Apr 22, 2024 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $1,940,000 Jan 22, 2024 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,130,000 Oct 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,980,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,490,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $1,080,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,610,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,120,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $1,500,000 Jan 20, 2022 Issue: None
  • $1,700,000 Oct 20, 2021 Issue: None
  • $1,220,000 Jul 20, 2021 Issue: None
  • $3,590,000 Apr 20, 2021 Issue: None
  • $1,210,000 Jan 21, 2021 Issue: None
  • $980,000 Oct 20, 2020 Issue: None
  • $2,620,000 Jul 20, 2020 Issue: None
  • $2,170,000 Apr 20, 2020 Issue: None
  • $1,020,000 Jan 22, 2020 Issue: None
  • $890,000 Oct 21, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Agriculture Taxation/Internal Revenue Code
  • $2,305,000 Jul 22, 2019 Issue: Health Issues Agriculture Medicare/Medicaid Consumer Issues/Safety/Products Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $2,740,000 Apr 22, 2019 Issue: Intelligence Animals Medicare/Medicaid Health Issues Agriculture Taxation/Internal Revenue Code
  • $900,000 Jan 22, 2019 Issue: Medicare/Medicaid Health Issues Animals Taxation/Internal Revenue Code
  • $1,760,000 Oct 22, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Animals Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $830,000 Jul 20, 2018 Issue: Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Budget/Appropriations
  • $3,310,000 Apr 20, 2018 Issue: Animals Budget/Appropriations Medicare/Medicaid Health Issues
  • $790,000 Jan 22, 2018 Issue: Animals Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Budget/Appropriations
  • $1,750,000 Oct 20, 2017 Issue: Budget/Appropriations Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $1,720,000 Jul 20, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Animals Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $1,970,000 Jul 20, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $1,000,000 Jan 23, 2017 Issue: Animals Budget/Appropriations Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $1,390,000 Oct 20, 2016 Issue: Animals Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $850,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Animals Trade (domestic/foreign) Budget/Appropriations
  • $3,260,000 Apr 20, 2016 Issue: Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues Animals
  • $650,000 Jan 20, 2016 Issue: Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues Budget/Appropriations Animals
  • $1,490,000 Oct 19, 2015 Issue: Animals Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $1,400,000 Jul 20, 2015 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $2,110,000 Apr 20, 2015 Issue: Animals Budget/Appropriations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
  • $490,000 Mar 25, 2015 Issue: Animals Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $1,160,000 Oct 20, 2014 Issue: Animals Health Issues Copyright/Patent/Trademark Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $1,170,000 Jul 21, 2014 Issue: Animals Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations
  • $2,000,000 Apr 21, 2014 Issue: Budget/Appropriations Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Copyright/Patent/Trademark Animals
  • $820,000 Jan 17, 2014 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Taxation/Internal Revenue Code Manufacturing Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues
  • $2,890,000 Oct 21, 2013 Issue: Animals Consumer Issues/Safety/Products Medicare/Medicaid Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Health Issues Trade (domestic/foreign) Manufacturing
  • $1,420,000 Oct 21, 2013 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Manufacturing
  • $900,000 Jul 22, 2013 Issue: Animals Consumer Issues/Safety/Products Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Budget/Appropriations Health Issues Manufacturing
  • $1,190,000 Jan 18, 2013 Issue: Medical/Disease Research/Clinical Labs Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Manufacturing
  • $2,430,000 Oct 19, 2012 Issue: Health Issues Taxation/Internal Revenue Code Manufacturing Medicare/Medicaid Medical/Disease Research/Clinical Labs Trade (domestic/foreign) Budget/Appropriations Consumer Issues/Safety/Products
  • $1,400,000 Jul 19, 2012 Issue: Consumer Issues/Safety/Products Health Issues Taxation/Internal Revenue Code Manufacturing Trade (domestic/foreign) Medicare/Medicaid
  • $4,490,000 Apr 20, 2012 Issue: Law Enforcement/Crime/Criminal Justice Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Manufacturing Trade (domestic/foreign) Consumer Issues/Safety/Products
  • $1,120,000 Jan 20, 2012 Issue: Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Manufacturing Law Enforcement/Crime/Criminal Justice Budget/Appropriations Consumer Issues/Safety/Products
  • $2,450,000 Oct 20, 2011 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Animals Law Enforcement/Crime/Criminal Justice Trade (domestic/foreign) Copyright/Patent/Trademark
  • $1,120,000 Jul 20, 2011 Issue: Budget/Appropriations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Consumer Issues/Safety/Products Medicare/Medicaid
  • $3,220,000 May 17, 2011 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid Budget/Appropriations Financial Institutions/Investments/Securities Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $1,285,000 Jan 20, 2011 Issue: Consumer Issues/Safety/Products Chemicals/Chemical Industry Budget/Appropriations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
  • $2,163,510 Oct 20, 2010 Issue: Animals Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Consumer Issues/Safety/Products Chemicals/Chemical Industry
  • $944,000 Jul 20, 2010 Issue: Animals Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Financial Institutions/Investments/Securities Chemicals/Chemical Industry Taxation/Internal Revenue Code
  • $3,220,000 Apr 19, 2010 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Financial Institutions/Investments/Securities Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $1,820,000 Jan 20, 2010 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $1,560,000 Oct 20, 2009 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Budget/Appropriations
  • $1,530,000 Jul 20, 2009 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $1,500,000 Apr 20, 2009 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $1,320,000 Jan 21, 2009 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $1,110,000 Oct 17, 2008 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $1,170,000 Jul 18, 2008 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations
  • $1,040,000 Apr 18, 2008 Issue: Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Medicare/Medicaid Budget/Appropriations
  • $2,530,000 Feb 13, 2008 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $2,300,000 Aug 13, 2007 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $1,980,000 Feb 14, 2007 Issue: Health Issues Medicare/Medicaid Budget/Appropriations Taxation/Internal Revenue Code
  • $2,070,000 Aug 11, 2006 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Budget/Appropriations
  • $1,980,000 Feb 09, 2006 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $1,700,000 Aug 15, 2005 Issue: Trade (domestic/foreign) Medicare/Medicaid Consumer Issues/Safety/Products
  • $1,820,000 Feb 14, 2005 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Consumer Issues/Safety/Products
  • $1,740,000 Aug 16, 2004 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Consumer Issues/Safety/Products
  • $3,040,000 Feb 27, 2004 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Consumer Issues/Safety/Products
  • $4,420,000 Aug 19, 2003 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Homeland Security
  • $4,670,294 Feb 14, 2003 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $2,660,000 Aug 20, 2002 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Medicare/Medicaid Environment/Superfund Medical/Disease Research/Clinical Labs
  • $3,420 Jul 24, 2002 Issue: Trade (domestic/foreign) Disaster Planning/Emergencies Health Issues Veterans Medicare/Medicaid Budget/Appropriations Environment/Superfund Medical/Disease Research/Clinical Labs
  • $2,780,000 Aug 09, 2001 Issue: Budget/Appropriations Environment/Superfund Trade (domestic/foreign) Manufacturing Taxation/Internal Revenue Code Health Issues Veterans Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $2,820,000 Feb 14, 2001 Issue: Trade (domestic/foreign) Manufacturing Taxation/Internal Revenue Code Health Issues Veterans Medicare/Medicaid Budget/Appropriations Environment/Superfund Medical/Disease Research/Clinical Labs
  • $302,000 Aug 14, 2000 Issue: Trade (domestic/foreign) Manufacturing Taxation/Internal Revenue Code Health Issues Veterans Medicare/Medicaid Budget/Appropriations Environment/Superfund Medical/Disease Research/Clinical Labs
  • $2,600,000 Feb 14, 2000 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Environment/Superfund Pharmacy Trade (domestic/foreign) Manufacturing Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Veterans Medicare/Medicaid
  • $2,720,000 Aug 16, 1999 Issue: Trade (domestic/foreign) Manufacturing Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Veterans Medicare/Medicaid Budget/Appropriations Environment/Superfund Pharmacy Medical/Disease Research/Clinical Labs

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Sample separating implement and sample analyzing device Feb. 16, 2021
  • Patent Title: Biomolecule analyzer Sep. 03, 2019
  • Patent Title: Method of treating inherited severe neutropenia Oct. 09, 2012
  • Patent Title: Tyrosine kinase inhibitors Feb. 22, 2011
  • Patent Title: Substituted piperidines that increase p53 activity and the uses thereof Feb. 08, 2011
  • Patent Title: Process for the preparation of ring compounds Nov. 30, 2010
  • Patent Title: Hiv integrase inhibitors Oct. 26, 2010
  • Patent Title: Process for {3-[2( Oct. 05, 2010
  • Patent Title: Hepatitis c virus assay systems Aug. 31, 2010
  • Patent Title: Anti-addl antibodies and uses thereof Aug. 24, 2010
  • Patent Title: Purification process for plasmid dna Aug. 03, 2010
  • Patent Title: Inhibitors of janus kinases Jul. 27, 2010
  • Patent Title: System and method for automated selection of t-cell epitopes Jul. 13, 2010
  • Patent Title: High affinity antibody antagonists of interleukin-13 receptor alpha 1 Jul. 13, 2010
  • Patent Title: Mitotic kinesin inhibitors Jun. 29, 2010
  • Patent Title: Human antibodies interacting with hiv gp41 Jun. 29, 2010
  • Patent Title: Mitotic kinesin inhibitors Jun. 08, 2010
  • Patent Title: Anti-addl monoclonal antibody and use thereof Jun. 08, 2010
  • Patent Title: Mitotic kinesin inhibitors May. 25, 2010
  • Patent Title: Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease May. 11, 2010
  • Patent Title: Anti-hypercholesterolemic compounds Apr. 27, 2010
  • Patent Title: Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors Apr. 20, 2010
  • Patent Title: Optimized expression of hpv 52 l1 in yeast Apr. 20, 2010
  • Patent Title: Non-immunostimulatory antibody and compositions containing the same Apr. 20, 2010
  • Patent Title: Prodrugs of diaryl-2-(5h)-furanone cyclooxygenase-2 inhibitors Mar. 30, 2010
  • Patent Title: Bicyclic amides Feb. 23, 2010
  • Patent Title: Mitotic kinesin inhibitors Feb. 23, 2010
  • Patent Title: 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists Feb. 09, 2010
  • Patent Title: Computer systems and methods for subdividing a complex disease into component diseases Jan. 26, 2010
  • Patent Title: Cetp inhibitors Jan. 26, 2010
  • Patent Title: Pyrazole amide derivatives, compositions containing such compounds and methods of use Jan. 19, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of MRK in WallStreetBets Daily Discussion

MRK News

Recent insights relating to MRK

CNBC Recommendations

Recent picks made for MRK stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MRK

MRK Top Shareholders
Shareholder
Shares Held
MRK Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MRK Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MRK Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top